Stock prices dropped sharply this week as the SPDR S&P 500 ETF Trust (NYSE: SPY) completed its worst first half of any year in more than half a century.
Todd Gordon, CNBC contributor and founder of New Age Wealth Advisors, joined Benzinga's PreMarket Prep show on Friday morning.
Gordon discussed the S&P 500 market weakness so far in 2022 and how he is positioning his clients' money heading into the second half of the year.
The U.S. Supreme Court continued its busy summer this week, issuing a landmark ruling limiting the mpower of the Environmental Protection Agency. The ruling could have significant financial implications for a number of energy sector stocks.
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall.
The news, announced Tuesday, June 28, could have a big impact on the share prices of vaccine makers.
Semiconductor stocks have taken a big hit so far in 2022, and one Wall Street analyst just adjusted his ratings on six semis heading into the second half of the year.
The Analyst: Bank of America analyst Vivek Arya made the following seven ratings changes on Wednesday:
The SPDR S&P 500 ETF Trust (NYSE: SPY) traded lower by 1% on Tuesday after the latest reading of consumer confidence suggests U.S. shoppers are taking notice of rising prices and falling stocks.
It's been a rough year so far for casino and online gambling stocks, but one firm has identified a handful of gambling stocks that investors should consider buying on the dip.
The Analyst: JMP Securities analyst Jordan Bender has initiated coverage of the following five stocks:
Three days after the U.S. Supreme Court struck down Roe v. Wade in one of the most potentially impactful rulings of the last century, a handful of women's health stocks are on the move on Monday in response to the news.